$27.55
-0.03[-0.11%]
At close: Apr 24
$27.55
0[0.00%]
After Hours: 4:06PM EDT
10x Genomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of 10x Genomics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/30/2024 | PM | TXG | Q1 | -$0.44 | -$0.50 | — | — | $134.28M | $142.80M | — | — | Get Alert |
02/15/2024 | PM | TXG | Q4 | -$0.15 | -$0.36 | -$0.24 | 33.33% | $156.23M | $182.80M | $183.98M | 0.64% | Get Alert |
11/02/2023 | PM | TXG | Q3 | -$0.37 | -$0.46 | -$0.44 | 4.35% | $131.07M | $151.26M | $153.64M | 1.58% | Get Alert |
08/03/2023 | PM | TXG | Q2 | -$0.57 | -$0.39 | -$0.53 | -35.90% | $114.61M | $138.97M | $146.82M | 5.65% | Get Alert |
05/03/2023 | PM | TXG | Q1 | -$0.38 | -$0.37 | -$0.44 | -18.92% | $114.50M | $128.82M | $134.28M | 4.24% | Get Alert |
02/15/2023 | PM | TXG | Q4 | -$0.16 | -$0.31 | -$0.15 | 51.61% | $143.53M | $148.69M | $156.23M | 5.07% | Get Alert |
11/02/2022 | PM | TXG | Q3 | -$0.15 | -$0.46 | -$0.37 | 19.57% | $125.30M | $129.58M | $131.07M | 1.15% | Get Alert |
08/08/2022 | PM | TXG | Q2 | -$0.10 | -$0.39 | -$0.57 | -46.15% | $115.84M | $117.19M | $114.61M | -2.20% | Get Alert |
05/04/2022 | PM | TXG | Q1 | -$0.11 | -$0.31 | -$0.38 | -22.58% | $105.82M | $113.34M | $114.50M | 1.02% | Get Alert |
02/16/2022 | PM | TXG | Q4 | -$0.08 | -$0.09 | -$0.16 | -77.78% | $112.22M | $148.53M | $143.53M | -3.37% | Get Alert |
11/03/2021 | PM | TXG | Q3 | -$0.65 | -$0.20 | -$0.15 | 25.00% | $71.82M | $122.62M | $125.30M | 2.18% | Get Alert |
08/04/2021 | PM | TXG | Q2 | -$0.41 | -$0.26 | -$0.10 | 61.54% | $42.91M | $112.85M | $115.84M | 2.65% | Get Alert |
05/05/2021 | PM | TXG | Q1 | -$0.22 | -$0.27 | -$0.11 | 59.26% | $71.91M | $102.51M | $105.82M | 3.23% | Get Alert |
02/17/2021 | PM | TXG | Q4 | -$0.07 | -$0.23 | -$0.08 | 65.22% | $75.29M | $100.40M | $112.22M | 11.77% | Get Alert |
11/10/2020 | PM | TXG | Q3 | -$0.33 | -$0.30 | -$0.65 | -116.67% | $61.21M | $61.23M | $71.82M | 17.29% | Get Alert |
08/11/2020 | PM | TXG | Q2 | — | -$0.55 | -$0.41 | 25.45% | $55.80M | $29.56M | $42.91M | 45.15% | Get Alert |
05/11/2020 | PM | TXG | Q1 | — | -$0.13 | -$0.22 | -69.23% | — | $73.42M | $71.91M | -2.06% | Get Alert |
02/18/2020 | PM | TXG | Q4 | — | -$0.11 | -$0.07 | 36.36% | — | $70.00M | $75.29M | 7.56% | Get Alert |
11/07/2019 | PM | TXG | Q3 | — | — | -$0.33 | — | — | — | $61.21M | — | Get Alert |
10x Genomics (TXG) is scheduled to report earnings on April 30, 2024. The last reported earnings were for reported on February 15, 2024 for Q4.
The Actual EPS was $-0.24, which beat the estimate of $-0.36.
The Actual Revenue was $184M, which beat the estimate of $182.8M.
Browse earnings estimates, EPS, and revenue on all stocks.